Pharmacokinetics of chloral hydrate poisoning treated with hemodialysis and hemoperfusion.
In a severe case of chloral hydrate intoxication treated with combined hemodialysis and hemoperfusion the pharmacokinetics of the metabolites trichloroethanol (TCE), trichloroethanol glucuronide (TCE-Glu) and trichloroacetic acid (TCA) were studied. Indications of delayed absorption and some slowing of metabolism were found. At a blood flow rate of 200 ml/min clearances by hemodialysis and hemoperfusion, respectively, in ml/min were estimated to be 188 and 156 for TCE, 184 and 181 for TCE-Glu, 142 and 91 for TCA. Clearance by hemoperfusion declined with time. The half-lives of TCE and TCA were 3.2 and 4.3 hours during combined hemodialysis and hemoperfusion. After termination of treatment the half-life of TCE was 12.8 hours, whereas TCA was metabolized so slowly, that no reliable calculation could be performed. We conclude that hemodialysis and hemoperfusion are equally and highly efficient in the treatment of chloral hydrate poisoning, but hemoperfusion may increase the risk of gastric bleeding more than hemodialysis. Hemodialysis may therefore be preferable and should be tried in spite of low blood pressure.
Buur
T
T
Department of Nephrology, University Hospital of Linköping, Sweden.
Larsson
R
R
Norlander
B
B
D000328:Adult; D002697:Chloral Hydrate / Q000493:pharmacokinetics / Q000506:poisoning*; D005023:Ethylene Chlorohydrin / Q000493:pharmacokinetics; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D006435:Renal Dialysis; D014238:Trichloroacetic Acid / Q000493:pharmacokinetics
D002697:Chloral Hydrate; D014238:Trichloroacetic Acid; D005023:Ethylene Chlorohydrin